Schedule 13D ownership disclosure

REPLICEL LIFE SCIENCES INC.

Security class unavailable · CUSIP: 76027P400

Event date: 2020-08-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,627,351
Percent of class
13.5100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085037-20-000066
Form type
SC 13D/A
Filer
REPLICEL LIFE SCIENCES INC.
CIK
CIK 1205059
Filed
Sep 17, 2020
Reporting period
Aug 18, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub